Integrin alpha V beta 1

Integrin alpha V beta 1

Integrin alpha V beta 1 Overview

Molecule Name
Integrin alpha-V/beta-1
Drug Development Progress
Drugs in Clinical Trials5
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
Background
Integrin alpha V beta 1 (αVβ1) is a widely expressed adhesion receptor formed by the non-covalent association of the αV and β1 (CD29) subunits. Its activity is regulated by a conformational shift from a folded, low-affinity state to an extended, high-affinity state, a process triggered by divalent cations and intracellular signaling. As a canonical RGD-binding integrin, it interacts with ligands including vitronectin, fibronectin, and osteopontin. This interaction is central to its role in mediating cell migration, where its modest binding affinity enables the cyclic attachment and detachment necessary for cell movement. Furthermore, αVβ1 is implicated in cellular differentiation and is co-opted by pathogens, such as foot-and-mouth disease virus, for host cell entry.

Integrin alpha V beta 1 Product List

Species
  • Human(3)
  • Cynomolgus(1)
  • Mouse(1)
  • Rat(1)
Tag
  • His Tag(3)
  • Flag Tag(1)
  • His Tag & Avi Tag(1)
  • Tag Free(1)
Host
  • HEK293(4)
  • CHO(2)
Conjugate
  • Unconjugated(5)
  • Biotin-labeled(1)
Grade
  • RUO(6)
Low Endotoxin
  • No(6)
You Have Viewed 1-6 Of 6 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IDL-2965IDL-2965Phase 2 ClinicalIndalo Therapeutics Inc
Idiopathic Pulmonary Fibrosis; Metabolic Dysfunction-Associated Steatotic Liver Disease
Details
BexotegrastPLN-74809Phase 2 ClinicalPliant Therapeutics Inc
Cholangitis, Sclerosing; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Respiratory Distress Syndrome, Adult
Details
PLN-1474PLN-1474Phase 1 ClinicalPliant Therapeutics Inc
Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease
Details
PLN-101095PLN-101095Phase 1 ClinicalPliant Therapeutics Inc
Solid tumours
Details
Cu-64-LLP2ACu-64-LLP2A; 64Cu-LLP2APhase 1 ClinicalUniversity Of Pittsburgh
Anemia, Sickle Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Multiple Myeloma; Waldenstrom Macroglobulinemia
Details
Customer Reviews